Loading...
Loading...
2 mins read
For years, research on depression has moved between broad explanations: chemical imbalances, large-scale neural circuits, environmental factors difficult to isolate. However, a more recent line of studies has begun to sharpen the focus, asking not only what changes in the brain, but in which specific cell types those alterations manifest.
In this direction lies a study published in Nature Genetics, based on the analysis of post-mortem human brain tissue. The research provides new evidence on the biological bases of depression by identifying concrete genetic alterations in certain types of brain cells, offering a more precise view of where some of the disruptions associated with this disorder occur, a condition that affects more than 264 million people worldwide and is one of the leading causes of disability.
The work was carried out by researchers at McGill University and the Douglas Institute, who identified two cell populations with altered genetic activity in people with depression. On the one hand, changes were observed in a specific type of excitatory neuron involved in mood regulation and stress response; on the other, in a subtype of microglia, immune cells in the brain responsible for regulating inflammatory processes. In both cases, numerous genes showed distinct expression patterns compared to brains of people without depression, suggesting alterations in key systems of brain function.
To achieve these results, the team used samples from the Douglas-Bell Canada Brain Bank, one of the few collections worldwide with brain tissue donated by individuals with psychiatric disorders. Using advanced single-cell genomics techniques, the researchers analyzed RNA and DNA from thousands of individual cells, mapping both genetic activity and the mechanisms regulating gene expression. The study included samples from 59 people with depression and 41 without the diagnosis.
According to the authors, this is the first time such precision has been achieved in identifying which cell types are implicated in depression by combining gene activity analysis with DNA regulatory mechanisms. This approach offers a clearer picture of where alterations are concentrated and deepens understanding of the disorder from a more localized biological perspective.
Beyond its scientific implications, the findings also challenge reductionist conceptions of depression. By showing measurable changes in specific brain cells, the research reinforces the idea that depression is not merely an emotional phenomenon, but a condition linked to concrete and observable modifications in brain biology.
As a next step, the team plans to study how these cellular alterations influence overall brain function and assess whether developing treatments targeted specifically at these cell types could open new therapeutic avenues. Without promising immediate solutions, the study provides a more precise framework for considering interventions aimed at cellular processes involved in mood regulation.